Gene · 8880
Papers1,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas. | Front Pharmacol | 2023 | 38053842 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals CLIC1 as a therapeutic vulnerability of gliomas. | Front Pharmacol | 2023 | 38027011 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds. | bioRxiv | 2023 | 38014036 | PubTator, text mining | PubMed |
| Practical multidisciplinary framework for the assessment and management of patients with unexplained chronic aerodigestive symptoms. | BMJ Open Gastroenterol | 2023 | 37996120 | PubTator, text mining | PubMed |
| Correction: MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. | Oncogene | 2023 | 37978227 | PubTator, text mining | PubMed |
| Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas. | Cell Biosci | 2023 | 37957701 | PubTator, text mining | PubMed |
| MYC function and regulation in physiological perspective. | Front Cell Dev Biol | 2023 | 37941901 | PubTator, text mining | PubMed |
| Precision medicine advancements in glioblastoma: A systematic review. | Biomedicine (Taipei) | 2023 | 37937301 | PubTator, text mining | PubMed |
| Genomic characterization of IDH-mutant astrocytoma progression to grade 4 in the treatment setting. | Acta Neuropathol Commun | 2023 | 37932833 | PubTator, text mining | PubMed |
| Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19. | Sci Rep | 2023 | 37932299 | PubTator, text mining | PubMed |
| IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. | Front Immunol | 2023 | 37928523 | PubTator, text mining | PubMed |
| Molecular and clinical characterization of ANG expression in gliomas and its association with tumor-related immune response. | Front Med (Lausanne) | 2023 | 37928479 | PubTator, text mining | PubMed |
| Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer. | J Transl Med | 2023 | 37915034 | PubTator, text mining | PubMed |
| Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival. | Clin Exp Med | 2023 | 37910256 | PubTator, text mining | PubMed |
| Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects. | Front Mol Biosci | 2023 | 37908227 | PubTator, text mining | PubMed |
| Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis. | Cancer Cell Int | 2023 | 37907993 | PubTator, text mining | PubMed |
| Circular RNAs: biology and clinical significance of breast cancer. | RNA Biol | 2023 | 37882644 | PubTator, text mining | PubMed |
| Protein modification by short-chain fatty acid metabolites in sepsis: a comprehensive review. | Front Immunol | 2023 | 37869005 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8880/papers?page=5